In the EU, the AI Act has been approved, carrying significant implications for medical device, technology, and pharmaceutical firms. In the US, ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the Marketing Authorisation Application, MAA, for the use of depemokimab in two indications. The submitted indicati ...

Donald Trump continues to make waves in biopharma; Sage rejects Biogen’s unsolicited takeover offer; the obesity space sees ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

High-quality evidence for the treatment of very rare diseases: IQWiG is involved in the EU project RealiseD Developing clinical trials to provide good evidence for very rare diseases, so that ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

The EUDA director said people using multiple drugs at once, violence, and political polarisation are key challenges for 2025.

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

The government agency says X no longer suits its communication needs.

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...